{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:15:38Z","timestamp":1791353738772,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI103083"],"award-info":[{"award-number":["R01-AI103083"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI150095"],"award-info":[{"award-number":["R01-AI150095"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21-AI168792"],"award-info":[{"award-number":["R21-AI168792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41-AI177204"],"award-info":[{"award-number":["R41-AI177204"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21-AI163606"],"award-info":[{"award-number":["R21-AI163606"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016086"],"award-info":[{"award-number":["P30CA016086"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.antiviral.2025.106145","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:25:40Z","timestamp":1742390740000},"page":"106145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Hepato-selective dihydroquinolizinones active against hepatitis A virus in vitro and in vivo"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3892-7605","authenticated-orcid":false,"given":"Ichiro","family":"Misumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhou","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6209-8520","authenticated-orcid":false,"given":"Zhengyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anilkumar","family":"Karampoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Whitmire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-7668","authenticated-orcid":false,"given":"Timothy","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M.","family":"Lemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4665-8348","authenticated-orcid":false,"given":"Yanming","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-6009","authenticated-orcid":false,"given":"You","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2025.106145_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105407","article-title":"Unexpected neurotoxicity in chronic toxicity studies with a HBV viral expression inhibitor","volume":"141","author":"Bopst","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.antiviral.2025.106145_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1124\/mol.108.048991","article-title":"Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity","volume":"74","author":"Evers","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2025.106145_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005792-199201000-00002","article-title":"Relapsing hepatitis A. Review of 14 cases and literature survey","volume":"71","author":"Glikson","year":"1992","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.antiviral.2025.106145_bib4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1021\/acs.jmedchem.3c01981","article-title":"Structure-activity relationships and discovery of (S)-6-Isopropyl-2-methoxy-3-(3-methoxypropoxy)-10-oxo-5,10-dihydro-6H-pyrido[1,2-h][1,7]naphthyridine-9-carboxylic acid (AB-452), a novel orally available HBV RNA destabilizer","volume":"67","author":"Gotchev","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2025.106145_bib5","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1021\/acs.jmedchem.8b01245","article-title":"Discovery of RG7834: the first-in-class selective and orally available small molecule hepatitis B virus expression inhibitor with novel mechanism of action","volume":"61","author":"Han","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2025.106145_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.aaf8325","article-title":"MAVS-dependent host species range and pathogenicity of human hepatitis A virus","volume":"353","author":"Hirai-Yuki","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2025.106145_bib7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031674","article-title":"Murine models of hepatitis A virus infection","volume":"9","author":"Hirai-Yuki","year":"2019","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.antiviral.2025.106145_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/infdis\/jiaa636","article-title":"Hepatitis A person-to-person outbreaks: epidemiology, morbidity burden, and factors associated with hospitalization-multiple states, 2016-2019","volume":"223","author":"Hofmeister","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2025.106145_bib9","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1093\/infdis\/jiae087","article-title":"The burden of hepatitis A outbreaks in the United States: health outcomes, economic costs, and management strategies","volume":"230","author":"Horn","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2025.106145_bib10","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/acsmedchemlett.1c00228","article-title":"Hepatoselective dihydroquinolizinone bis-acids for HBsAg mRNA degradation","volume":"12","author":"Hwang","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2025.106145_bib11","doi-asserted-by":"crossref","first-page":"a031716","DOI":"10.1101\/cshperspect.a031716","article-title":"Globalization and the changing epidemiology of hepatitis A virus","volume":"8","author":"Jacobsen","year":"2018","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.antiviral.2025.106145_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2025.106145_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108859","article-title":"A genome-wide CRISPR screen identifies UFMylation and TRAMP-like complexes as host factors required for hepatitis A virus infection","volume":"34","author":"Kulsuptrakul","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2025.106145_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/toxsci\/kfac009","article-title":"Neurotoxicity of an hepatitis B virus (HBV) transcript inhibitor in 13-week rat and monkey studies","volume":"186","author":"Lake","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.antiviral.2025.106145_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/v16030323","article-title":"Preclinical antiviral and safety profiling of the HBV RNA destabilizer AB-161","volume":"16","author":"Lam","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2025.106145_bib16","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1073\/pnas.1101939108","article-title":"Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA","volume":"108","author":"Lanford","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2025.106145_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2017.08.034","article-title":"Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention","volume":"68","author":"Lemon","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2025.106145_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1124\/jpet.301.2.551","article-title":"Tissue expression, ontogeny, and inducibility of rat organic anion transporting polypeptide 4","volume":"301","author":"Li","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.antiviral.2025.106145_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00057-24","article-title":"Biochemical analysis of the host factor activity of ZCCHC14 in hepatitis A virus replication","volume":"98","author":"Li","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2025.106145_bib20","article-title":"The ZCCHC14\/TENT4 complex is required for hepatitis A virus RNA synthesis","volume":"119","author":"Li","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2025.106145_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00058-21","article-title":"Iminosugar glucosidase inhibitors reduce hepatic inflammation in HAV-infected Ifnar1(-\/-) mice","author":"Misumi","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2025.106145_bib22","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.30329","article-title":"PAPD5\/7 are host factors that are required for hepatitis B virus RNA stabilization","volume":"69","author":"Mueller","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2025.106145_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2017.10.014","article-title":"A novel orally available small molecule that inhibits hepatitis B virus expression","volume":"68","author":"Mueller","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2025.106145_bib24","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"M\u00fcller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2025.106145_bib25","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.15585\/mmwr.mm6743a5","article-title":"Update: recommendations of the advisory committee on immunization practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel","volume":"67","author":"Nelson","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2025.106145_bib26","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031708","article-title":"Natural history, clinical manifestations, and pathogenesis of hepatitis A","volume":"8","author":"Shin","year":"2018","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.antiviral.2025.106145_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01496-22","article-title":"Macrophage depletion reactivates fecal virus shedding following resolution of acute hepatitis A in Ifnar1-\/- mice","volume":"96","author":"Shiota","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2025.106145_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-106-2-221","article-title":"Hepatitis A virus in stool during clinical relapse","volume":"106","author":"Sjogren","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2025.106145_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00640-20","article-title":"The dihydroquinolizinone compound RG7834 inhibits the polyadenylase function of PAPD5 and PAPD7 and accelerates the degradation of matured hepatitis B virus surface protein mRNA","volume":"65","author":"Sun","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2025.106145_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-023-00461-2","article-title":"Hepatitis A virus infection","volume":"9","author":"Van Damme","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.antiviral.2025.106145_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/dmd.114.061580","article-title":"Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics","volume":"43","author":"Wang","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.antiviral.2025.106145_bib33","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1124\/dmd.111.041814","article-title":"Hepatic uptake in the dog: comparison of uptake in hepatocytes and human embryonic kidney cells expressing dog organic anion-transporting polypeptide 1B4","volume":"39","author":"Wilby","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.antiviral.2025.106145_bib34","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41564-019-0425-6","article-title":"Constitutive expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses","volume":"4","author":"Yamane","year":"2019","journal-title":"Nat. microbiol."},{"issue":"5","key":"10.1016\/j.antiviral.2025.106145_bib35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bmcl.2015.01.016","article-title":"Transporter-mediated tissue targeting of therapeutic molecules in drug discovery","volume":"25","author":"Zhou","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354225000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354225000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:33:14Z","timestamp":1762252394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354225000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"alternative-id":["S0166354225000713"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2025.106145","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepato-selective dihydroquinolizinones active against hepatitis A virus in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2025.106145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106145"}}